Alzheimer’s disease

According to the CDC (Center for Disease control and prevention), Alzheimer’s disease (AD) is the most common type of dementia. It is a progressive disease that begins with mild memory loss and possibly leads to loss of the ability to carry on a conversation and respond to the environment. Alzheimer’s disease involves parts of the brain that control thought, memory, and language and It can seriously affect a person’s ability to carry out daily activities.

Alzheimer’s disease is not a normal part of aging. Memory problems are typically one of the first warning signs of Alzheimer’s disease and related dementias.

Stem cells have improved characteristics of self-renewal, proliferation, differentiation, and recombination with the advent of stem cell technology and the transformation of these cells into different types of central nervous system neurons and glial cells. Stem cell treatment has been successful in AD animal models. Recent preclinical studies on stem cell therapy for AD have proved to be promising. Cell replacement therapies, such as human embryonic stem cells or induced pluripotent stem cell-derived neural cells, have the potential to treat patients with AD.


Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References